+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathy Drug"

Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Regional Outlook and Forecast, 2024 - 2031 - Product Thumbnail Image

Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • April 2024
  • 265 Pages
From
North America Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031 - Product Thumbnail Image

North America Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031

  • Report
  • April 2024
  • 128 Pages
From
LAMEA Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031 - Product Thumbnail Image

LAMEA Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031

  • Report
  • April 2024
  • 133 Pages
From
Europe Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031 - Product Thumbnail Image

Europe Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031

  • Report
  • April 2024
  • 134 Pages
From
Asia Pacific Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031 - Product Thumbnail Image

Asia Pacific Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031

  • Report
  • April 2024
  • 135 Pages
From
Diabetic Peripheral Neuropathy (Metabolic Disorder) - Drugs in Development, 2021 - Product Thumbnail Image

Diabetic Peripheral Neuropathy (Metabolic Disorder) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 162 Pages
  • Global
From
Optic Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Optic Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 73 Pages
  • Global
From
Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 97 Pages
  • Global
From
Familial Amyloid Neuropathies - Pipeline Review, H1 2020 - Product Thumbnail Image

Familial Amyloid Neuropathies - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 98 Pages
  • Global
From
Optic Neuropathy Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Optic Neuropathy Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 80 Pages
  • Global
From
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 94 Pages
  • Global
From
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 68 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 166 Pages
  • Global
From
Diabetic Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 143 Pages
  • Global
From
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2020 - Product Thumbnail Image

Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 119 Pages
  • Global
From
Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 74 Pages
  • Global
From
Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 85 Pages
  • Global
From
Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 62 Pages
  • Global
From
Leber s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2018 - Product Thumbnail Image

Leber s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2018

  • Drug Pipelines
  • September 2018
  • 86 Pages
  • Global
From
Loading Indicator

The Neuropathy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat diseases and disorders of the brain, spinal cord, and peripheral nervous system. Neuropathy drugs are used to treat a variety of conditions, including diabetic neuropathy, postherpetic neuralgia, and chemotherapy-induced peripheral neuropathy. These drugs are typically administered orally, intravenously, or topically, and may include anticonvulsants, antidepressants, and opioids. The Neuropathy Drug market is highly competitive, with a variety of companies offering products to treat a range of conditions. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. Other companies, such as Eli Lilly, Sanofi, and AstraZeneca, also offer products in this market. Show Less Read more